Sanara MedTech (NASDAQ:SMTI) reported quarterly sales of $9.70 million which beat the analyst consensus estimate of $7.81 million by 24.20 percent. This is a 54.53 percent increase over sales of $6.28 million the same period last year.
Sagaliam Acquisition Corp. Confirms Funding And Extension Of Deadline To Complete Initial Business Combination To January 23, 2023
Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it was exercising its
